Comparison of pain after abdominal surgery in patients receiving ketorolac and nasocalcin spray or lidocaine and nasocalcin spray

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230710058733N1

Enrollment

Registered

2023-09-26

Start date

2021-09-20

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after abdominal surgery. Unspecified complication of procedure

Interventions

Intervention 1: 2 puffs of nasocalcin and Ketorolac 30 mg ampoules were received intravenously. After patients enter the operating room, patients under general anesthesia with the same drugs (propofol

Eligibility

Sex/Gender

All

Age

15 Years to 75 Years

Inclusion criteria

Inclusion criteria: Being 15-75 years old Sign a personal consent form to enter the study American Society of Anesthesiologists 1-2 Non-use of drugs and alcohol Elective surgery

Exclusion criteria

Exclusion criteria: Decreased level of consciousness Hemodynamic disorder Abnormal intraoperative bleeding Length of operation more than 4 hours

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 1 hour and 6, 12, 24 hours after the operation, the amount. Method of measurement: Visual Analogue Scale.	—

Secondary

Measure	Time frame
The amount of narcotic (pethidine) received after the operation. Timepoint: After surgery. Method of measurement: Amount of drug used.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mahnaz Narimani Zamanabadi

Islamic Azad University

Mahdieh.ir72@yahoo.com+98 21 7719 0836

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026